Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.

HBW Over The Counter Podcast
HBW finds out all about the EU Omnibus package • Source: Citeline Design Team

The European Commission has put forward a series of proposals designed to simplify European Union sustainability rules and boost the region’s competitiveness.

As a result, application dates for EU due diligence and sustainability reporting requirements have been delayed by two years.

Other proposals such as reducing the frequency of reporting and narrowing the scope of supply chains are still subject to trilogue negotiation.

In the first of two Over the Counter episodes, CEN Group director Jasper Crone returns to the podcast to explain what might change, where he thinks this is all coming from and why companies should consider getting ready for new sustainability reporting rules even if they are no longer directly affected.

Timestamps

2:00 – Introductions

4:30 – EU sustainability reporting regulation recap

7:20 – Omnibus simplification package

12:00 – Simplification, or confusion?

19:00 – Where’s this all coming from?

23:30 – Why sustainability reporting is still good for business

25:40 – What’s all this got to do with competitiveness?

Guest Bio

Jasper Crone is a director at CEN Group , a corporate sustainability consultancy which helps businesses maximize their corporate sustainability potential, improving performance and ESG disclosure.

Crone leads on several client teams, covering the implementation of internal controls and sustainability data, setting sustainability and net zero targets and developing programs for implementation and operationalization of objectives.

He is experienced in sustainability reporting and the CEN Group assists clients with all aspects of sustainability reporting, whether regulatory, investor or customer driven. He brings a range of skills from 20 years of experience in the financial markets, in both the investment banking and investment management industries. He has a BSc in biology from University of Bristol and is a CFA charter holder.

You can contact Jasper via email: jasper.crone@cen-grp.com

More from Podcasts

Over The Counter: Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

 
• By 

HBW Insight speaks to Haleon's UK & Ireland general manager Jo Cooper about how she plans to translate the firm's ambitious global growth strategy to a local context.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

Over The Counter: Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

 
• By 

HBW Insight speaks to Kerry Group's RDA director for digestive health, Mathieu Millette, about the opportunity represented by the global trend for GLP-1 agonists for consumer health.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

More from Supply Chain

Over The Counter: EU Omnibus And ESG, What You Need To Know, With CEN Group’s Jasper Crone

 
• By 

HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.

US Consumer Health, Beauty Sectors: Expecting Tariff Policy Changes, Buckling Up For The Ride

 

As firms in OTC drug, dietary supplement and personal care/beauty sectors reported results for January-March period after Trump announced reciprocal tariffs, they buckled up for more changes in the president’s thinking likely to affect consumer spending as well as their costs.

OTC Drug, Supplement Trade Groups Argue For Tariff Exemption, International Supply Chain

 

Potential for supply disruption coupled with manufacturers’ costs for moving supply chains to US emphasized by industry trade groups in comments submitted to Department of Commerce on whether pharmaceutical and dietary ingredients should remain exempted from tariffs President Trump has imposed.